These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 6956473

  • 1. The prophylaxis of AV nodal re-entry tachycardia.
    Tonkin AM, Shorne L.
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():135-43. PubMed ID: 6956473
    [Abstract] [Full Text] [Related]

  • 2. [Electrophysiologic effects of calcium channel blockers on supraventricular tachycardia in children].
    Fujino H, Fujiseki Y, Shimada M.
    J Cardiol; 1989 Mar; 19(1):307-15. PubMed ID: 2810047
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M.
    Indian Heart J; 1996 Mar; 48(2):133-7. PubMed ID: 8682552
    [Abstract] [Full Text] [Related]

  • 5. Verapamil in prophylaxis of paroxysmal atrioventricular nodal reentrant tachycardia.
    Tonkin AM, Aylward PE, Joel SE, Heddle WF.
    J Cardiovasc Pharmacol; 1980 Mar; 2(5):473-86. PubMed ID: 6157944
    [Abstract] [Full Text] [Related]

  • 6. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia.
    Rowland E, McKenna WJ, Gülker H, Krikler DM.
    Circ Res; 1983 Feb; 52(2 Pt 2):I163-8. PubMed ID: 6831649
    [Abstract] [Full Text] [Related]

  • 7. Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias.
    Sellers TD, Kirchhoffer JB, Modesto TA.
    Prog Clin Biol Res; 1987 Feb; 230():283-99. PubMed ID: 3295883
    [Abstract] [Full Text] [Related]

  • 8. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M, Kuhl AJ, Lüderitz B.
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Electrophysiologic study of patients with short P-R interval and normal QRS complex.
    Moro C, Cosío FG.
    Eur J Cardiol; 1980 Feb; 11(2):81-90. PubMed ID: 7363927
    [Abstract] [Full Text] [Related]

  • 12. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.
    Schwab JO, Eichner G, Schmitt H, Schrickel J, Yang A, Balta O, Lüderitz B, Lewalter T.
    Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591
    [Abstract] [Full Text] [Related]

  • 13. [Effects of verapamil and disopyramide phosphate on the termination, reinduction and long-term prevention of paroxysmal supraventricular tachycardia].
    Tsuchioka Y, Nakagawa H, Yamagata T, Sakura E, Hashimoto M, Okamoto M, Matsuura H, Kajiyama G.
    Kokyu To Junkan; 1990 Mar; 38(3):243-8. PubMed ID: 2109870
    [Abstract] [Full Text] [Related]

  • 14. [Left ventricular systolic time intervals during paroxysmal supraventricular tachycardia: the difference between A-V nodal re-entry and A-V re-entry].
    Matsui Y, Iwasaka T, Karakawa M, Matsuura T, Hata T, Inada M.
    J Cardiol; 1992 Mar; 22(4):679-85. PubMed ID: 1343634
    [Abstract] [Full Text] [Related]

  • 15. Accessory pathway reciprocating tachycardia.
    Obel OA, Camm AJ.
    Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
    [Abstract] [Full Text] [Related]

  • 16. [The mechanism of the chronic supraventricular tachycardia: an intracavitary electrophysiological study (author's transl)].
    Raviele A, Artusi L, Delise P, Sartori F, Pascotto P, Piccolo E.
    G Ital Cardiol; 1977 May; 7(11):1057-68. PubMed ID: 924066
    [Abstract] [Full Text] [Related]

  • 17. [Use of non-invasive transdermal stimulation of the heart in selecting an anti-arrhythmia drug in a patient with supraventricular paroxysmal tachycardia with a re-entry mechanism within the atrioventricular node].
    Prochaczek F, Gałecka J, Becker A.
    Kardiol Pol; 1988 May; 31(6):337-42. PubMed ID: 3236620
    [No Abstract] [Full Text] [Related]

  • 18. Electrophysiologic effects of intravenous diltiazem in patients with recurrent supraventricular tachycardias.
    Roy D, Marchand E, Chabot M, Gagné P, Waters DD, Bourassa MG.
    Can J Cardiol; 1985 May; 1(5):302-5. PubMed ID: 3842093
    [Abstract] [Full Text] [Related]

  • 19. Verapamil in cardiac arrhythmias: an overview.
    Vohra J.
    Clin Exp Pharmacol Physiol Suppl; 1982 May; 6():129-34. PubMed ID: 6749351
    [Abstract] [Full Text] [Related]

  • 20. [Electrophysiological analysis of atrioventricular and intraventricular conduction in bi- and tri-fascicular blocks].
    Ducceschi V, Sarubbi B, Mayer MS, De Divitiis M, Briglia N, Scialdone A, Santangelo L, Iacono A.
    Minerva Cardioangiol; 1997 Mar; 45(3):87-93. PubMed ID: 9213825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.